- Home
- Industry Reports
- Healthcare
- Healthcare IT
- North America Drug Discovery Informatics Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Drug discovery is the process through which new medicines are identified. In the past, most of the drugs have been discovered by identifying the active ingredient from the traditional remedies. Improvements to traditional computational drug applications will continue to provide the incremental benefits. Drug discovery informatics is an extremely complex process that involves generation of larger volumes of data. At present, the market for drug discovery informatics is largely unmet.
North America Drug Discovery Informatics Market Size & Growth:
The North America drug discovery informatics Market size is projected to reach approximately $ XX m by the end of 2024 with a CAGR close to X% from $XX m in 2018 during the forecast timeline 2018-2024. The Key factors that drive the growth of the market include the rising R&D expenditure, the increasing focus on drug discovery, need to control the drug discovery and the development costs, high throughput screening methods and So On. The development decisions for the drug should be taken in the earlier stages by the skilled professionals to get the expected drug.
North America Drug Discovery Informatics Market Share:
Various parameters divided the North America drug discovery informatics market. By the Solution, they are divided into Software and services. Among them, software plays an important role not only in drug discovery but also in drug development. Nowadays software companies are investing a lot of money for drug discovery. By the End-User, they are divided into Pharmaceutical & Biotechnology and Contract research organisations. Among them, Contract research organisations will play a significant role because the contract research organisations will provide support to the pharmaceuticals, biotechnology and medical devices in the form of research services. By the Function, they are divided into docking, molecular modelling, target data analysis and others. Among them, molecular modelling plays a vital role because Docking is a method in molecular modelling which predicts the preferred orientation of one molecule. By Geography, United States has the most significant market share regarding drug discovery due to rise in clinical discovery ventures as well as various activities carried out by research institutes.
North America Drug Discovery Informatics Market Trends:
- Dassault Systemes and Ipsen Sign collaborative agreement to develop innovative programs to support Ipsen’s drug discovery.
- Infosys partnered with a global pharmaceutical company to compress the discovery cycle by helping scientists analyse data, collaborative and make informed decisions regarding compounds.
- Clarivate analytics launches new product suite which will reduce the amount of time and risk for researchers in reaching their targets.
North America Drug Discovery Informatics Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Infosys
- Collaborative Drug Discovery
- Dassault Systemes
- Certara Pharma
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Overview
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analysis
4. Market Dynamics
4.1 Drivers
4.1.1 Increasing focus on drug discovery
4.1.2 Rising R&D Expenditure
4.1.3 Need to control drug discovery and development costs
4.2 Restraints
4.2.1 Increase in setup cost of informative software
4.2.2 Lack of data availability
4.3 Opportunities
4.3.1 Growth in the biotechnology industry
4.3.2 Patent expiry
4.4 Challenges
4.4.1 Scarcity of skilled professionals
5. North America Drug Discovery Informatics Market – By Function
5.1 Docking
5.2 Molecular Modelling
5.3 Sequencing and Target Data Analysis
5.4 Libraries and Database Preparation
5.5 Others
6. North America Drug Discovery Informatics Market – By Solution
6.1 Software
6.2 Services
7. North America Drug Discovery Informatics Market – By End-User
7.1 Pharmaceutical and Biotechnology Companies
7.2 Contract Research Organizations
7.3 Other End-Users
8. North America Drug Discovery Informatics Market – By Geography
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.2.4 Rest of North America
9. North America Drug Discovery Informatics Market – By Company Profiles
9.1 Collaborative drug discovery
9.2 GVK Biosciences
9.3 Drug Development Informatics
9.4 Selvita
9.5 Charles River Laboratories
9.6. Certara Pharma
9.7 Open Eye Scientific Software
9.8 Cortellis Informatics
9.9 Infosys
9.10 PerkinElmer
10. North America Drug Discovery Informatics Market – By Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,991.88 - €6,639.62
- INR: ₹180,043.09 - ₹600,143.64
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,706.75 - £5,689.16
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Drug discovery is the process through which new medicines are identified. In the past, most of the drugs have been discovered by identifying the active ingredient from the traditional remedies. Improvements to traditional computational drug applications will continue to provide the incremental benefits. Drug discovery informatics is an extremely complex process that involves generation of larger volumes of data. At present, the market for drug discovery informatics is largely unmet.
North America Drug Discovery Informatics Market Size & Growth:
The North America drug discovery informatics Market size is projected to reach approximately $ XX m by the end of 2024 with a CAGR close to X% from $XX m in 2018 during the forecast timeline 2018-2024. The Key factors that drive the growth of the market include the rising R&D expenditure, the increasing focus on drug discovery, need to control the drug discovery and the development costs, high throughput screening methods and So On. The development decisions for the drug should be taken in the earlier stages by the skilled professionals to get the expected drug.
North America Drug Discovery Informatics Market Share:
Various parameters divided the North America drug discovery informatics market. By the Solution, they are divided into Software and services. Among them, software plays an important role not only in drug discovery but also in drug development. Nowadays software companies are investing a lot of money for drug discovery. By the End-User, they are divided into Pharmaceutical & Biotechnology and Contract research organisations. Among them, Contract research organisations will play a significant role because the contract research organisations will provide support to the pharmaceuticals, biotechnology and medical devices in the form of research services. By the Function, they are divided into docking, molecular modelling, target data analysis and others. Among them, molecular modelling plays a vital role because Docking is a method in molecular modelling which predicts the preferred orientation of one molecule. By Geography, United States has the most significant market share regarding drug discovery due to rise in clinical discovery ventures as well as various activities carried out by research institutes.
North America Drug Discovery Informatics Market Trends:
- Dassault Systemes and Ipsen Sign collaborative agreement to develop innovative programs to support Ipsen’s drug discovery.
- Infosys partnered with a global pharmaceutical company to compress the discovery cycle by helping scientists analyse data, collaborative and make informed decisions regarding compounds.
- Clarivate analytics launches new product suite which will reduce the amount of time and risk for researchers in reaching their targets.
North America Drug Discovery Informatics Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Infosys
- Collaborative Drug Discovery
- Dassault Systemes
- Certara Pharma
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Overview
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analysis
4. Market Dynamics
4.1 Drivers
4.1.1 Increasing focus on drug discovery
4.1.2 Rising R&D Expenditure
4.1.3 Need to control drug discovery and development costs
4.2 Restraints
4.2.1 Increase in setup cost of informative software
4.2.2 Lack of data availability
4.3 Opportunities
4.3.1 Growth in the biotechnology industry
4.3.2 Patent expiry
4.4 Challenges
4.4.1 Scarcity of skilled professionals
5. North America Drug Discovery Informatics Market – By Function
5.1 Docking
5.2 Molecular Modelling
5.3 Sequencing and Target Data Analysis
5.4 Libraries and Database Preparation
5.5 Others
6. North America Drug Discovery Informatics Market – By Solution
6.1 Software
6.2 Services
7. North America Drug Discovery Informatics Market – By End-User
7.1 Pharmaceutical and Biotechnology Companies
7.2 Contract Research Organizations
7.3 Other End-Users
8. North America Drug Discovery Informatics Market – By Geography
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.2.4 Rest of North America
9. North America Drug Discovery Informatics Market – By Company Profiles
9.1 Collaborative drug discovery
9.2 GVK Biosciences
9.3 Drug Development Informatics
9.4 Selvita
9.5 Charles River Laboratories
9.6. Certara Pharma
9.7 Open Eye Scientific Software
9.8 Cortellis Informatics
9.9 Infosys
9.10 PerkinElmer
10. North America Drug Discovery Informatics Market – By Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.